This company seems to have been delisted
Reason: filed for bankruptcy
Last recorded trade on: June 14, 2024
Source: https://www.biopharmadive.com/news/acorda-bankruptcy-asset-sale-merz-stalking-horse/712010/
Reason: filed for bankruptcy
Last recorded trade on: June 14, 2024
Source: https://www.biopharmadive.com/news/acorda-bankruptcy-asset-sale-merz-stalking-horse/712010/
Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
-95.64%
Change (1 year)
Categories
Acorda Therapeutics (ACOR) - P/B ratio
P/B ratio as of June 2025 : -0.0044
According to Acorda Therapeutics
's latest financial reports the company has a price-to-book ratio of 0.00709839.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Acorda Therapeutics - P/B ratio (from 2006 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | -0.1187 | -159.54% |
| 2022-12-31 | 0.1993 | 12.51% |
| 2021-12-31 | 0.1771 | 7.4% |
| 2020-12-31 | 0.1649 | -47.32% |
| 2019-12-31 | 0.3131 | -74.07% |
| 2018-12-31 | 1.21 | -37.4% |
| 2017-12-31 | 1.93 | 47.74% |
| 2016-12-31 | 1.31 | -57.2% |
| 2015-12-31 | 3.05 | -3.72% |
| 2014-12-31 | 3.17 | 16.84% |
| 2013-12-31 | 2.71 | 5.76% |
| 2012-12-31 | 2.56 | -44.38% |
| 2011-12-31 | 4.61 | -34.04% |
| 2010-12-31 | 6.99 | 0.37% |
| 2009-12-31 | 6.96 | 86.42% |
| 2008-12-31 | 3.73 | -62.25% |
| 2007-12-31 | 9.89 | -50.72% |
| 2006-12-31 | 20.1 | |
| 2005-12-31 | N/A | |
| 2003-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | 3.37 | -76,342.94% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 1.82 | -41,369.40% | 🇺🇸 USA |
 Affimed
AFMD | 0.1549 | -3,605.00% | 🇩🇪 Germany |
 Sarepta Therapeutics
SRPT | 1.73 | -39,317.16% | 🇺🇸 USA |